Impact of Lebrikizumab on Patient-Reported Outcomes in Atopic Dermatitis: Prospective and Post Hoc Analyses of a Phase 2b Clinical Trial Demonstrate Clinically Meaningful Improvements. J of Skin 2020, 4 (6), s94. https://doi.org/10.25251/skin.4.supp.94.